In-hospital Cardiac ArrestNCASNCT02368392
National Cardiac Arrest Survey
An observational study of In-hospital Cardiac Arrest, run by Ministry of Health, Sri Lanka at 1 site in Sri Lanka.
Trial summary
The aim of this study is to describe incidence of "in-hospital" deaths and outcomes after attempted cardiac arrest resuscitation, availability of resuscitation equipment and medical staff training in state Hospitals of Sri Lanka. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- In-hospital Cardiac Arrest
- What is being tested?
- Exposure for cardiac arrests
- How many people
- 537 participants
- Where
- 1 siteSri Lanka
- Study dates
- Jul 2014to Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients admitting to state hospitals in Sri Lanka
Who may be able to join
- All admissions to state hospitals in Sri Lanka
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
Official title: National Cardiac Arrest Survey of Sri Lanka
The aim of this study is to describe incidence of "in-hospital" deaths and outcomes after attempted cardiac arrest resuscitation, availability of resuscitation equipment and medical staff training in state Hospitals of Sri Lanka.
Read the detailed description
4 General objective To describe incidence of "in-hospital" deaths, outcomes after attempted cardiac arrest resuscitation and availability of resuscitation equipment in Sri Lankan state Hospitals.
4.1 Specific objectives
- To describe the incidence of in-hospital deaths in state sector Hospitals in Sri Lanka.
- To describe the availability of resources for cardiac arrest management in these settings.
- To describe the incidence of attempted resuscitation after cardiac arrests.
- To describe the immediate outcomes after attempted resuscitation for cardiac arrests.
- To describe the ICU, Hospital and 30 day post discharge outcomes of these patients
- To describe the health related quality of patients who survived to 1 year 5 Methodology 5.1 Study one 5.1.1 Study design One week cross-sectional study
5.1.2 Study setting In all state sector Hospitals with (Base Hospitals and above)
5.1.3 Administrative process Once ethical review process has been completed, The Hospital Directors/Medical Superintendent (and through them the Hospital Consultants) will be officially informed of the study by the office of the Deputy Director General (Education, Training and Research) (DDG ET\&R) at the Ministry of Health.
Medical Officers will be nominated for the study through the same office. A small financial incentive will be provided for these Doctors during this study period (as below). The investigators will also seek permission from the Steering committee of National Intensive Care Surveillance to obtain ICU admission, outcome and follow-up data for IHCA patients from the NICS database.
5.1.4 Study population All patients who died in-hospital or those on whom CPR was attempted within the time period of the study.
5.1.4.1 Exclusions criteria
- Dead on arrival at Hospital
- Neonate (less than 28 days)
5.1.5 Study sample Entire population
5.1.6 Study period One week period in July/August 2014
5.1.7 Sample size One week period will be studied
5.1.8 Sampling method Not applicable
5.1.9 Data collection tools During the study period, nominated and pre-trained medical officers from each Hospital will complete a questionnaire using an online form on a daily basis. The data collector will interview each Ward Sister, House Officer or senior nurse twice (around 7 am and 7 pm) daily. Non- ward areas such as operating theatres, emergency rooms will also be covered. This process will be piloted in five hospitals prior to the study to fine tune the process.
5.1.9.1 Data validation Death register in the ward/mortuary or in the Matron's office will be used to validate the data collected on Hospital deaths and any discrepancies resolved. Random validation of the data collected at Hospital level will be done centrally on a daily basis during the one-week period.
ICU admission reasons will also be collected from all ICUs during this period to detect ICU admissions due to in-hospital cardiac arrests, which can also be used as a method of validation.
5.1.10 Study variables The following will be collected daily during the one week period
- Number of in-ward deaths
- Number of attempted resuscitations
- Number of successful resuscitations and their subsequent locations
- Number admitted to ICU (name and BHT number) following resuscitation and location of the ICUs
- Total number of in-ward patients at midnight, daily, during the study period.
- In addition at the beginning of the study period the facilities available for resuscitation will be collected at ward/theatre against a standard resuscitation council equipment checklist. The staff participation in previous resuscitation training will be gathered anonymously at the same time. This information will only be collected once.
5.2 Study two 5.2.1 Study design Longitudinal study
5.2.2 Study setting All Intensive Care Units to which the patients successfully resuscitated have been admitted.
5.2.3 Study period From the beginning of the study period of study 1 above, and until 30 days after ICU discharge for the last patient admitted to an ICU after successful resuscitation, up to a maximum of 90 days from the start of the study period.
5.2.4 Sample size All patients admitted to an ICU after successful resuscitation from study 1 above, will be included. We are unable to estimate a sample size for this study as the number of patients admitted after cardiac arrests over this period is not known. The purpose of this part of the study is to actually know what number of patients are admitted to ICU after resuscitation and what their outcomes are. No causative association is proposed as an product of this part of the study.We have selected a one-week recruitment period as this is a national study and we feel this is a feasible duration for us.
5.2.5 Sampling method All patients who had successful resuscitation and were admitted to ICU in study 1, will be included.
5.2.6 Data collection tools The data will be gathered, after appropriate permission has been sought, as above, from the National Intensive Care Surveillance (NICS) database. No new data will need to be gathered from these ICUs. If the ICU is not part of the NICS network, we will follow up these resuscitated patients in these non-NICS ICUs. Health related Quality of Life,neurological and disability status of these patients will be reviewed using SF-12, EQ-5Dand MRS from those who survived to 1 year.
5.2.7 Study variables The following data will be collected for each eligible patient using the National Intensive Care Surveillance database where the ICU is part of the network.
- Outcomes at ICU discharge
- Outcomes at Hospital discharge
- Outcomes at 30 day post discharge In the non-NICS ICUs we will determine ICU outcomes by contacting the ICUs at least once a week. We will also determine hospital and 30 days outcome by obtaining a contact telephone number of the patient or the next of kin. This is similar to the methodology we currently employ for patients admitted to NICS ICUs.
- Health related Quality of Life, neurological and disability status of patients who survived at 6 months and up to 1 year 6 Statistical analysis: Data will be analyzed using Statistical Package for Social Sciences 18 and Stata 13.
Discrete variables are expressed as counts (percentage) and continuous variables as means (± standard deviations (SD) and median (inter quartile range (IQR)). For description of variables standard descriptive statistics will be used. For comparison of continuous variables t test will be used while chi square will be used to compare discrete variables.
Multivariate logistic regression analysis will be used to describe the prevalence of selected factors as antecedents or contributory features of cardiac arrests.
7 Ethics 7.1 Consent: Permission will be taken from the relevant Authorities of the Ministry of Health and Hospitals as described in detail above. Personal identifier data of patients will not be collected except for Name, BHT number, address and telephone number of those successfully resuscitated. The investigators and data collectors will not come in direct contact with the patients except when determining 30 day outcome.
7.2 Risks to the patient: There are no obvious risks to patient.
7.3 Benefits: Potential benefits are many at individual patient level, Hospital level and national level. The study will enable quantification of the burden of recognized cardiac arrests, their outcomes and possible antecedent/contributory factors to enable the formulation of concrete strategies to improve care.
7.4 Confidentiality: Data extraction sheet will be completed only by the nominated medical officers or by the proposed expert committee. Data will be stored in a computer and only the authorized personal will have access to this information and the information will be password protected and backed up.
7.5 Dissemination of information: The findings will be disseminated in the form of abstracts submitted for scientific session, journal articles and presentations. They may be used for local or national guideline preparation.
7.6 Beneficiaries: There are three main categories of beneficiaries. The Ministry of Health benefits from information by knowing the ground situation and being able to plan and direct the donors where improvement are needed both in resources as well as capacity building. The staff benefits by being able to identify areas of improvement in the services given for IHCA and resuscitation and thus has the opportunity to improve the skills on resuscitation. Thus data can be used to develop services and the human resources in improving IHCA management and patient out come.
- Conditions
- In-hospital Cardiac Arrest
- Being tested
- Exposure for cardiac arrests
- Keywords
- in-hospital cardiac arrest, quality of life after cardiac arrest, survival after cardiac arrest, resources for cardiac arrest
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exposure for cardiac arrestsOther
There is no particular intervention. This study merely observes the occurrence of cardiac arrests
| Study group | Role | What they receive |
|---|---|---|
| Cardiac Arrest | Those who get in-hospital cardiac arrests Receives: Other: Exposure for cardiac arrests | |
| Non Cardiac Arrest | Those who do not get in-hospital cardiac arrest Receives: Other: Exposure for cardiac arrests |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mortality
Mortality 30 days after cardiac arrest
Measured: 30 day
Secondary outcomes (3)
ICU admission
ICU admissions following cardiac arrests
Measured: 30 day
Quality of Life
Quality of life of survivors of cardiac arrests
Measured: 1 year
Survival
1 year survival after cardiac arrest
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Feb 2015 (estimated)
- Study startJul 2014
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for In-hospital Cardiac ArrestStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 537 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ministry of Health, Sri Lanka
- Sponsor type
- Other government
- Collaborators
- National Intensive Care Surveillance, Mahidol Oxford Tropical Medicine Research Unit, Government Medical Officers Association of Sri Lanka
- Responsible party
- Principal investigator, Pubudu De Silva, Ministry of Health, Sri Lanka
- Investigators
- Rashan Haniffa, MBBS, FRCA, Study chair, Mahidol Oxford Tropical Medicine Research UnitSaroj Jayasinghe, MD, FRCP, Study chair, University of Colombo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02368392
- Sponsor's protocol ID
- NCAS
- Acronym
- NCAS
- Status last verified
- Feb 2016
- First submitted
- 14 Feb 2015
- Last updated
- 17 Feb 2016
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- National Cardiac Arrest Survey of Sri Lanka
- ClinicalTrials.gov ID
- NCT02368392
- Acronym / sponsor ID
- NCAS / NCAS
- Conditions
- In-hospital Cardiac Arrest
- Keywords
- in-hospital cardiac arrest, quality of life after cardiac arrest, survival after cardiac arrest, resources for cardiac arrest
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 537 participants (actual)
- Lead sponsor
- Ministry of Health, Sri LankaOther government
- Collaborators
- National Intensive Care Surveillance, Mahidol Oxford Tropical Medicine Research Unit, Government Medical Officers Association of Sri Lanka
- Study start
- Jul 2014
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 23 Feb 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to describe incidence of "in-hospital" deaths and outcomes after attempted cardiac arrest resuscitation, availability of resuscitation equipment and medical staff training in state Hospitals of Sri Lanka.
Detailed description
4 General objective To describe incidence of "in-hospital" deaths, outcomes after attempted cardiac arrest resuscitation and availability of resuscitation equipment in Sri Lankan state Hospitals.
4.1 Specific objectives
- To describe the incidence of in-hospital deaths in state sector Hospitals in Sri Lanka.
- To describe the availability of resources for cardiac arrest management in these settings.
- To describe the incidence of attempted resuscitation after cardiac arrests.
- To describe the immediate outcomes after attempted resuscitation for cardiac arrests.
- To describe the ICU, Hospital and 30 day post discharge outcomes of these patients
- To describe the health related quality of patients who survived to 1 year 5 Methodology 5.1 Study one 5.1.1 Study design One week cross-sectional study
5.1.2 Study setting In all state sector Hospitals with (Base Hospitals and above)
5.1.3 Administrative process Once ethical review process has been completed, The Hospital Directors/Medical Superintendent (and through them the Hospital Consultants) will be officially informed of the study by the office of the Deputy Director General (Education, Training and Research) (DDG ET\&R) at the Ministry of Health.
Medical Officers will be nominated for the study through the same office. A small financial incentive will be provided for these Doctors during this study period (as below). The investigators will also seek permission from the Steering committee of National Intensive Care Surveillance to obtain ICU admission, outcome and follow-up data for IHCA patients from the NICS database.
5.1.4 Study population All patients who died in-hospital or those on whom CPR was attempted within the time period of the study.
5.1.4.1 Exclusions criteria
- Dead on arrival at Hospital
- Neonate (less than 28 days)
5.1.5 Study sample Entire population
5.1.6 Study period One week period in July/August 2014
5.1.7 Sample size One week period will be studied
5.1.8 Sampling method Not applicable
5.1.9 Data collection tools During the study period, nominated and pre-trained medical officers from each Hospital will complete a questionnaire using an online form on a daily basis. The data collector will interview each Ward Sister, House Officer or senior nurse twice (around 7 am and 7 pm) daily. Non- ward areas such as operating theatres, emergency rooms will also be covered. This process will be piloted in five hospitals prior to the study to fine tune the process.
5.1.9.1 Data validation Death register in the ward/mortuary or in the Matron's office will be used to validate the data collected on Hospital deaths and any discrepancies resolved. Random validation of the data collected at Hospital level will be done centrally on a daily basis during the one-week period.
ICU admission reasons will also be collected from all ICUs during this period to detect ICU admissions due to in-hospital cardiac arrests, which can also be used as a method of validation.
5.1.10 Study variables The following will be collected daily during the one week period
- Number of in-ward deaths
- Number of attempted resuscitations
- Number of successful resuscitations and their subsequent locations
- Number admitted to ICU (name and BHT number) following resuscitation and location of the ICUs
- Total number of in-ward patients at midnight, daily, during the study period.
- In addition at the beginning of the study period the facilities available for resuscitation will be collected at ward/theatre against a standard resuscitation council equipment checklist. The staff participation in previous resuscitation training will be gathered anonymously at the same time. This information will only be collected once.
5.2 Study two 5.2.1 Study design Longitudinal study
5.2.2 Study setting All Intensive Care Units to which the patients successfully resuscitated have been admitted.
5.2.3 Study period From the beginning of the study period of study 1 above, and until 30 days after ICU discharge for the last patient admitted to an ICU after successful resuscitation, up to a maximum of 90 days from the start of the study period.
5.2.4 Sample size All patients admitted to an ICU after successful resuscitation from study 1 above, will be included. We are unable to estimate a sample size for this study as the number of patients admitted after cardiac arrests over this period is not known. The purpose of this part of the study is to actually know what number of patients are admitted to ICU after resuscitation and what their outcomes are. No causative association is proposed as an product of this part of the study.We have selected a one-week recruitment period as this is a national study and we feel this is a feasible duration for us.
5.2.5 Sampling method All patients who had successful resuscitation and were admitted to ICU in study 1, will be included.
5.2.6 Data collection tools The data will be gathered, after appropriate permission has been sought, as above, from the National Intensive Care Surveillance (NICS) database. No new data will need to be gathered from these ICUs. If the ICU is not part of the NICS network, we will follow up these resuscitated patients in these non-NICS ICUs. Health related Quality of Life,neurological and disability status of these patients will be reviewed using SF-12, EQ-5Dand MRS from those who survived to 1 year.
5.2.7 Study variables The following data will be collected for each eligible patient using the National Intensive Care Surveillance database where the ICU is part of the network.
- Outcomes at ICU discharge
- Outcomes at Hospital discharge
- Outcomes at 30 day post discharge In the non-NICS ICUs we will determine ICU outcomes by contacting the ICUs at least once a week. We will also determine hospital and 30 days outcome by obtaining a contact telephone number of the patient or the next of kin. This is similar to the methodology we currently employ for patients admitted to NICS ICUs.
- Health related Quality of Life, neurological and disability status of patients who survived at 6 months and up to 1 year 6 Statistical analysis: Data will be analyzed using Statistical Package for Social Sciences 18 and Stata 13.
Discrete variables are expressed as counts (percentage) and continuous variables as means (± standard deviations (SD) and median (inter quartile range (IQR)). For description of variables standard descriptive statistics will be used. For comparison of continuous variables t test will be used while chi square will be used to compare discrete variables.
Multivariate logistic regression analysis will be used to describe the prevalence of selected factors as antecedents or contributory features of cardiac arrests.
7 Ethics 7.1 Consent: Permission will be taken from the relevant Authorities of the Ministry of Health and Hospitals as described in detail above. Personal identifier data of patients will not be collected except for Name, BHT number, address and telephone number of those successfully resuscitated. The investigators and data collectors will not come in direct contact with the patients except when determining 30 day outcome.
7.2 Risks to the patient: There are no obvious risks to patient.
7.3 Benefits: Potential benefits are many at individual patient level, Hospital level and national level. The study will enable quantification of the burden of recognized cardiac arrests, their outcomes and possible antecedent/contributory factors to enable the formulation of concrete strategies to improve care.
7.4 Confidentiality: Data extraction sheet will be completed only by the nominated medical officers or by the proposed expert committee. Data will be stored in a computer and only the authorized personal will have access to this information and the information will be password protected and backed up.
7.5 Dissemination of information: The findings will be disseminated in the form of abstracts submitted for scientific session, journal articles and presentations. They may be used for local or national guideline preparation.
7.6 Beneficiaries: There are three main categories of beneficiaries. The Ministry of Health benefits from information by knowing the ground situation and being able to plan and direct the donors where improvement are needed both in resources as well as capacity building. The staff benefits by being able to identify areas of improvement in the services given for IHCA and resuscitation and thus has the opportunity to improve the skills on resuscitation. Thus data can be used to develop services and the human resources in improving IHCA management and patient out come.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Cardiac Arrest | – | Other: Exposure for cardiac arrestsThose who get in-hospital cardiac arrests |
| Non Cardiac Arrest | – | Other: Exposure for cardiac arrestsThose who do not get in-hospital cardiac arrest |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients admitting to state hospitals in Sri Lanka
Key inclusion criteria (1 listed)
- All admissions to state hospitals in Sri Lanka
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exposure for cardiac arrestsThere is no particular intervention. This study merely observes the occurrence of cardiac arrests | Other | Cardiac Arrest, Non Cardiac Arrest |
Primary outcome
Mortality
Time frame: 30 day
Mortality 30 days after cardiac arrest
3 secondary outcomes
ICU admission
Time frame: 30 day
Quality of Life
Time frame: 1 year
Survival
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2016.
Related trials for In-hospital Cardiac Arrest
Not yet recruitingObservational study
CAROTID DOPPLER AND CEREBRAL OXIMERY IN POST CARDIAC ARREST ICU PATIENTS
Cardiac Arrest (CA), Carotid Doppler
Active, not recruitingPhase 3
The Danish Out-of-Hospital Cardiac Arrest Study
Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome
Not yet recruiting
Compression-Only Versus Standard Basic Life Support Training in Nursing Students
Cardiopulmonary Resuscitation, Out-of-Hospital Cardiac Arrest
Not yet recruiting
Execution of Prehospital Transesophageal Echocardiography During Cardiopulmonary Resuscitation in Patients With Out-of-hospital Cardiac Arrest
Out-of-hospital Cardiac Arrest (OHCA)
Active, not recruiting
The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest
Cardiac Arrest, Out-Of-Hospital
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rashan Haniffa, MBBS, FRCA study chair
Mahidol Oxford Tropical Medicine Research Unit
Saroj Jayasinghe, MD, FRCP study chair
University of Colombo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of In-hospital Cardiac Arrest, run by Ministry of Health, Sri Lanka at 1 site in Sri Lanka.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sri Lanka. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mortality (time frame: 30 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2016.